01 1Emcure Pharmaceuticals
01 1TENOFOVIR DISOPROXIL FUMARATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-08-16
Pay. Date : 2024-07-15
DMF Number : 37273
Submission : 2022-07-29
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 37273.
Remarkably, this DMF maintains an Active status since its submission on July 29, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 16, 2024, and payment made on July 15, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
